Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

First clinical data on RG-7212 show target modulation and signs of efficacy

Nov. 29, 2012

Japanese scientists present new humanized monoclonal antibodies

Nov. 28, 2012

Adcetris receives FDA orphan drug designation for mycosis fungoides

Nov. 27, 2012

Chugai and Nippon Shinyaku agree on GA-101 development for NHL in Japan

Nov. 27, 2012

Preclinical assessment of a novel bispecific antibody for the treatment of prostate cancer

Nov. 27, 2012

A novel bispecific antibody shows tumor specificity in vivo

Nov. 21, 2012

Immunovative Therapies expands collaboration with the University of Arizona

Nov. 16, 2012

European orphan product designation granted to algenpantucel-L

Nov. 15, 2012

Transgene and EORTC to collaborate on phase IIb trial of TG-4001

Nov. 15, 2012

Interim results for CVax show encouraging immune response

Nov. 15, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...